SCHEMBL24820600

SCHEMBL24820600

O=C(O)c1cc(F)ccc1-c1cc(Cl)nc(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 8/20 0.48
KEAP1 Q14145 2/20 0.46
DHODH Q02127 3/20 0.46
NFE2L2 Q16236 1/20 0.45
TTR P02766 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44
DHFR P00374 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
LMNA P02545 1/20 0.44
ALB P02768 1/20 0.44
HMGB1 P09429 1/20 0.44
HPGD P15428 1/20 0.44
CXCL12 P48061 1/20 0.44
HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30792061 1.00 EIF4E (0.48) EIF4EKEAP1DHODHNFE2L2TTR
SCHEMBL31319312 0.86 POLB (0.43) EIF4EKEAP1DHODHNFE2L2TTR
SCHEMBL24820593 0.86 GRM2 (0.45) KEAP1
SCHEMBL30792148 0.85 ALDH1A1 (0.53) EIF4EDHODHALDH1A1HSD17B10KDM4E
SCHEMBL24820734 0.85 ALDH1A1 (0.53) EIF4EDHODHALDH1A1HSD17B10KDM4E
SCHEMBL24820591 0.82 KDM4E (0.49) ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL30792152 0.82 KDM4E (0.49) ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL6488777 0.80 ANO1 (0.52) EIF4EKEAP1DHODHTTRALDH1A1
SCHEMBL6498591 0.79 HSD17B10 (0.58) EIF4EKEAP1DHODHTTRALDH1A1
SCHEMBL31586500 0.79 HSD17B10 (0.58) EIF4EKEAP1DHODHTTRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4637749-A2 CBL-B MODULATORS AND USES THEREOF Nimbus Clio, Inc. (US) 2025-10-29 EP disclosed
WO-2024137674-A2 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2024-06-27 WO disclosed
WO-2024086730-A1 HETEROCYCLIC CBL-B INHIBITORS FOR THE TREATMENT OF CANCER HOTSPOT THERAPEUTICS, INC. (US) 2024-04-25 WO disclosed
CN-117858707-A CBL-B modulators and uses thereof 林伯士克莱奥公司 2024-04-09 CN disclosed
WO-2022272248-A1 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2022-12-29 WO disclosed